GLP-1 analogs
![PDF] Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/86bbc20c1f90516619b981d247b1d6cdb8e7b90b/3-Figure1-1.png "PDF] Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial | Semantic Scholar")
PDF] Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial | Semantic Scholar
![exenatide [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c "exenatide [TUSOM | Pharmwiki]")
exenatide [TUSOM | Pharmwiki]
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors | Circulation
A schematic representation of the mechanisms of increased macrophage... | Download Scientific Diagram
Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies - Metabolism - Clinical and Experimental
Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing
Hypothalamic Insulin-Sensitizing Effect of Exenatide in Dietary Induced Rat Model of Obesity | Bentham Science
A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology
Mechanisms by which GLP-1 agonists may exert beneficial effects on the... | Download Scientific Diagram
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes - ScienceDirect
Differential Protective Effects of Exenatide, an Agonist of GLP-1 Receptor and Piragliatin, a Glucokinase Activator in Beta Cell Response to Streptozotocin-Induced and Endoplasmic Reticulum Stresses
Exendin‐4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant - Yap - 2019 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
JAMA Neurology on Twitter: "Analysis of #exosomes in serum can provide insights into mechanism of action of drugs in the #brain. Read about this example using exenatide in #Parkinson's disease https://t.co/KMTrnB4Sx6 https://t.co/seb8Pudspu" /
Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes - Clinical Therapeutics
Exenatide - Wikipedia
Pharmacokinetic/pharmacodynamic studies on exenatide in diabetic rats | Acta Pharmacologica Sinica
Mechanism of the beneficial and protective effects of exenatide in diabetic rats in: Journal of Endocrinology Volume 220 Issue 3 (2014)
A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology
Frontiers | GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms | Pharmacology
Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium - Journal of the Neurological Sciences
GLP-1 receptor agonists in type 2 diabetes: An underused asset? Updated January 2021 - DiabetesontheNet
Structures of native GLP-1, exenatide, and liraglutide. The N-terminal... | Download Scientific Diagram
Frontiers | GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects | Endocrinology
